Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate

Journal of the American Society of Nephrology

Volumn 12, Issue 6, 2001, Pages 1164-1172

  Markowitz, Glen S ^a   Appel, Gerald B ^a   Fine, Paul L ^b   Fenves, Andrew Z ^c   Loon, Nicholas R ^d   Jagannath, Sundar ^e   Kuhn, Joseph A ^f   Dratch, Adam D ^g   D'Agati, Vivette D ^a  

^a Columbia Coll of Phys and Surgeons ^*  (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d Department of Internal Medicine   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f MEDICAL CENTER OF DELAWARE   (United States)

^g Lehigh Valley Nephrology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PAMIDRONIC ACID; VINCRISTINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CARCINOMA; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; MULTIPLE MYELOMA; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL;

EID: 0035007762     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Korbet SM, Genchi R, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27: 647-651, 1996
2. Haas M, Spargo BH, Coventry S: Increasing incidence of focal segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study. Am J Kidney Dis 26: 740-750, 1995
3. Haas M, Meehan SM, Karrision TG, Spargo BH: Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30: 621-631, 1997
4. D'Agati V: The many masks of focal segmental glomerulosclerosis. Kidney Int 46: 1223-1241, 1994
5. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996
6. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424, 1994
7. D'Agati VD, Suh J, Carbone L, Appel GB: The pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35: 1358-1370, 1989
8. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopathological and follow-up study. Kidney Int 56: 2203-2213, 1999
9. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999
10. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD, for the Myeloma Aredia Study Group: Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334: 488-493, 1996
11. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffernan M, Mellars K, Reitsma DJ, for the Protocol 19 Aredia Breast Cancer Study Group: Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. J Clin Oncol 16: 2038-2044, 1998
12. Physician's Desk Reference, 54th Ed., Montvale, NJ, Medical Economics Company, 2000, pp 1998-2002
13. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs M, Blacklock H, Bell R, Simeone JF, Reitsma DJ, Heffernan M, Seaman J, Knight RD, for the Myeloma Aredia Study Group: Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. J Clin Oncol 16: 593-602, 1998
14. Adami S, Zamberlan N: Adverse effects of bisphosphonates: A comparative review. Drug Safety 14: 158-170, 1996
15. Zojer N, Keck AV, Pecherstorfer M: Comparative tolerability of drug therapies for hypercalcemia of malignancy. Drug Safety 21: 389-406, 1999
16. Green JR, Seltenmeyer Y, Jaeggi KA, Widler L: Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models. Pharmacol Toxicol 80: 225-230, 1997
17. Tyrrell CJ, Collinson M, Madsen EL, Ford JM, Colemen T: Intravenous pamidronate: Infusion rate and safety. Ann Oncol 5[Suppl 7]: S27-S29, 1994
18. Coroneos E, Petrusevska G, Varghese F, Truong LD: Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy. Am J Kidney Dis 28: 888-892, 1996
19. Bertani T, Rocchi G, Sacchi G, Mecca G, Remuzzi G: Adriamycin-induced glomerulosclerosis in the rat. Am J Kidney Dis 7: 12-19, 1986
20. Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M: Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29: 502-510, 1986
21. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 122: 481-487, 1986
22. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD: Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11: 1439-1448, 2000
23. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58: 173-181, 2000
24. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, Burns GC, D'Agati VD, Winston JA, Klotman ME, Klotman PE: Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 11: 2079-2087, 2000
25. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC: Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88: 2961-2978, 2000
26. Amin D, Cornell SA, Gustafson SK, Needle SJ, Ullrich JW, Bilder GE, Perrone MH: Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J Lipid Res 33: 1657-1663, 1992
27. Zhang FL, Casey PJ: Protein prenylation: Molecular mechanisms and dysfunctional consequences. Annu Rev Pharmacol Toxicol 37: 143-166, 1997
28. Clark EA, King WG, Brugge JS, Symons M, Hynes RO: Integrin-mediated signals regulated by members of the rho family of GTPases. J Cell Biol 142: 573-586, 1998
29. Ridley AJ, Paterson HF, Johnnston CL, Diekmann D, Hall A: The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70: 401-410, 1992
30. Zhang D, Udagawa N, Nakamura I, Murakami H, Saito S, Yamasaki K, Shibasaki Y, Morii N, Narumiya S, Takahashi N: The small GTP-binding protein rho p21 is involved in bone resorption by regulating cytoskeletal organization in osteoclasts. J Cell Sci 108: 2285-2292, 1995
31. Rogers MJ, Ji X, Russell RG, Blackburn GM, Williamson MP, Bayless AV, Ebetino FH, Watts DJ: Incorporation of bisphosphonates into adenine nucleotides by amoebae of the cellular slime mould Dictyostelium discoideum. Biochem J 303: 303-311, 1994
32. Hiroi-Furuyama E, Kameda T, Hiura K, Mano H, Miyazawa K, Nakamaru Y, Watanabe-Mano M, Okuda N, Shimada J, Yamamoto Y, Hakeda Y, Kumegawa M: Etidronate (EHDP) inhibits osteoclastic bone resorption, promotes apoptosis, and disrupts actin rings in isolate-mature osteoclasts. Calcif Tissue Int 64: 219-223, 1999
33. Kunzmann V, Bauer E, Feurle J, Tony FW, Wilhelm M: Stimulation of γδ T cells by aminobisphosphonates and induction of anti-plasma cell activity in multiple myeloma. Blood 96: 384-392, 2000
34. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40: 453-460, 1991
35. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334: 878-883, 1996